MedTrace Logo

S8600-S9031-S9333-A, Study of DNA in Samples From Patients With Acute Myeloid Leukemia

NCT01434329 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2016-04-15

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood and bone marrow from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients respond to treatment.

PURPOSE: This research trial studies DNA in samples from patients with acute myeloid leukemia.

Conditions

Interventions

GENETIC

DNA methylation analysis

GENETIC

gene expression analysis

GENETIC

microarray analysis

OTHER

laboratory biomarker analysis

OTHER

medical chart review

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • SWOG Cancer Research Network

    lead NETWORK

Principal Investigators

  • Min Fang, MD, PhD · Fred Hutchinson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2015-12-31
Completion
2015-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01434329 on ClinicalTrials.gov